ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag salary pharma academia funding

2015 Life Sciences Salary Survey
Amanda B. Keener and Karen Zusi | Nov 1, 2015 | 8 min read
This year’s survey highlights dramatic regional, sector, and gender variations.
Life Sciences Salary Survey 2011
Jef Akst and Edyta Zielinska | Dec 1, 2011 | 10+ min read
US salaries are starting to recover after last year’s survey recorded the first-ever drop.
Best Places to Work Academia, 2011
The Scientist | Jul 1, 2011 | 9 min read
Whether it’s attending a Scottish dance party or asking physics buffs to custom build your tools, researchers at this year’s top institutions are getting creative at work.
Industry vs Academia
The Scientist Staff | Apr 15, 2001 | 10+ min read
To conduct this survey, The Scientist invited 1800 readers via E-mail to respond to a web-based survey form. There were a total of 220 responses from March 2 to 12, 2001, a response rate of 12.2%. Have you held research positions in both academia and industry? (Positions may include graduate research, industrial internships, or any other research positions - paid or unpaid - in both work environments).   Percent Count Answers 72.6% 159/219 Yes 27.4% 60/219 No
Single Nucleotide Polymorphisms: Big Pharma Hedges its Bets
Eugene Russo | Jul 18, 1999 | 7 min read
SNP CENTRAL: A genetics researcher takes to the bench at the Wellcome Trust's Sanger Centre in Cambridge, England. The sequencing center and its London sponsor provided key leadership in the SNP Consortium, a public-private venture to find and map 300,000 single nucleotide polymorphisms. The Wellcome Trust helped entice 10 pharmaceutical firms to join the consortium by putting up $14 million of the project's estimated $45 million price tag. The Sanger Centre will provide much of the radiation h
Start It Up
Dan Cossins | Apr 1, 2013 | 8 min read
Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.
From Private to Public
Victoria Stern | Jan 13, 2010 | 5 min read
From Private to Public As head of a unique pharma-academia consortium, Aled Edwards has helped scientists solve the 3D structures of hundreds of disease-related proteins and deposited them in an open access bank—at half the usual cost. By Victoria Stern As an undergraduate at McGill University in Montreal, Aled Edwards spent most of his time playing football and enjoying various intramural sports, like baseball and basketball—and in th
Two Distinct Career Paths Offer Clear Choices
James Kling | Jul 5, 1998 | 6 min read
Big Pharma: Big markets. Traditional science. Big future and lofty salaries. Biotech: Lots of competition for smaller markets. Cutting-edge science. Iffy future, but tempting stock options. Such are the widely held perceptions regarding the industry sectors that employ life science researchers. Those perceptions have become clichés, and like all great clichés, they're not altogether accurate--but they do contain a kernel of truth. The real truth is, the maturing biotech industr
Earthquake Scientists Hope That Recent Rumblings Will Lead To More Funding
Jeffrey Mervis | Apr 1, 1990 | 9 min read
The San Francisco disaster proved the urgency of work toward mitigating damage as well as predicting when future quakes will strike WASHINGTON -- The physical aftershocks from last fall's deadly earthquake in San Francisco have ceased. But earthquake scientists are hoping that the political aftershocks from that devastating event, and the recent smaller trembler near Los Angeles, persist long enough to invigorate a field that has suffered from more than a decade of neglect since the launching
Will Life Sciences Follow Suit?
Richard Gallagher | Jun 6, 2004 | 3 min read
Arash of globalization is transferring upscale jobs offshore. This is the politically charged business practice of sending high-paying jobs out of the United States and Western Europe to Eastern Europe and developing countries, where salaries are considerably lower.For us, there are two questions: Will life sciences research, industrial or academic, follow this offshore trend? And if so, who will be the winners and the losers?The life sciences have so far been pretty deaf to the siren song of ou

Run a Search

ADVERTISEMENT